Opinion: Biosimilars could disappear if the Supreme Court overturns the ACA
Congress must prepare for the unexpected and mitigate risk by ensuring that the the Biologics Price Competition and Innovation Act, which paved the way for biosimilars, can stand on its…
With the sense of urgency rightly focused on slowing or stopping the spread of Covid-19, it seems like everything else in the news, and in health care, has come to a grinding halt. Yet important decision-making continues in the background, including some that could have long-lasting effects on health care today and in the future.
One of these is the decision by the U.S. Supreme Court to hear , a case that will decide whether most
